Crossmark

Desmopressin dosing in children using real-world data and pharmacokinetic/pharmacodynamic model simulations

Published Online: 2024-10-26

Published Print: 2025-06

Authors

Yen, Kevin https://orcid.org/0000-0001-8632-3633
Hughes, Emma

Savic, Rada

Srinivasan, Shylaja
License Information

Text and Data Mining valid from 2024-10-26

Version of Record valid from 2024-10-26
More Information

Article History

Received: 12 March 2024

Revised: 19 September 2024

Accepted: 26 September 2024

First Online: 26 October 2024

Competing interests

: The authors declare no competing interests.

: This study was approved by Institutional Review Board of University of California San Francisco. Informed consent was waived by Institutional Review Board as data for this study were generated from retrospective review of clinical data.

Document is current